OncoCyte Corp Cash Flow Reinvestment Rate
Latest as of September 2014:
1.86x
OncoCyte Corp cash flow reinvestment rate. OncoCyte Corp (OCX) has a Cash Flow Reinvestment Rate of 1.86x as of September 2014, reinvesting $13.00K (capex $13.00K ) from operating cash flow of $7.00K. See OCX free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
1.86x
(Capex + Investments) / Operating CF
Total Reinvested
$13.00K
Capex + Investments
Operating Cash Flow
$7.00K
USD
Capital Expenditures
$13.00K
USD
OncoCyte Corp Cash Flow Reinvestment Rate by Year (None–None)
OncoCyte Corp cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for OncoCyte Corp. For the full cash flow conversion analysis, see OncoCyte Corp operating cash flow efficiency.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow